Nasdaq suspends Windtree (WINT): -80% in 24 hours, moving to OTC and BNB strategy in jeopardy

Related

Balancer hack: $117.46M drained from V2, forks pause

Balancer hack was reported at 09:18 UTC on November...

Zerohash MiCA Licence Signals 3 Things to Watch in Q4 2025

The reported zerohash mica licence puts Zerohash at the...

Prince Andrew faces fallout after 2019 palace tour and £1.4m deal

Prince Andrew arranged a private Buckingham Palace tour in...

More difficulties for the price of BTC

Today as well, the price of Bitcoin (BTC) is...

France taxes crypto assets over €2M at 1%

France’s proposal to tax large crypto holdings has renewed...

Share

The suspension from Nasdaq for Windtree Therapeutics (ticker WINT), due to non-compliance with listing requirements and accompanied by an intraday collapse of –80%, has sparked strong fears among investors and raised questions about the recent initiative of treasury in BNB (initial commitment of $60 million with potential up to $200 million), indicating an already fragile financial balance.

According to the collected data, the stock went from about $0.48 before the notice to $0.11 at the close on August 21, 2025, confirming the very substantial intraday loss. Industry analysts monitoring small-cap biotech companies note that similar situations typically lead to a compression of capitalization and a significant reduction in liquidity in the first weeks following the delisting.